BridgeBio Oncology Therapeutics Inc.

BBOT

BBOTBridgeBio Oncology Therapeutics Inc. US flag

NASDAQ Global Market

2.85

USD

+0.03

- -

228.50MMarket Cap

Profitability (USD)

Profitability Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -
Return on Assets (%)	- -	-87.26	-43.76
Return on Capital (%)	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -
Gross Margin (%)	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -
Pretax Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	3
ST Debt	- -	- -	1
LT Debt	- -	- -	2
Total Debt/EBITDA	- -	- -	-0.02
Net Debt/EBITDA	- -	0.38	2.57
Total Debt/EBIT	- -	- -	-0.02
Net Debt/EBIT	- -	0.38	2.56
EBITDA to Interest Expense	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -
Interest Expense	- -	- -	- -
Common Equity/Total Assets	-1,946.16	-108.73	91.68
Long-Term Debt/Equity (%)	- -	- -	0.55
Long-Term Debt/Capital (%)	- -	- -	0.54
Long-Term Debt/Total Assets (%)	- -	- -	0.5
Total Debt/Equity (%)	- -	- -	0.67
Total Debt/Capital (%)	- -	- -	0.67
Total Debt/Total Assets (%)	- -	- -	0.62
Net Debt to Equity	0.22	17.27	-90.9
Net Debt/Capital (%)	0.22	14.73	-930.15
EBITDA	-65	-81	-145
EBITDA-CapEx	-65	-81	-146
Operating Income (Loss)	-65	-81	-146

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.01	7.95	12.14
Current Ratio	0.23	8.1	12.34
Quick Ratio	0.12	7.95	12.15
CFO/Avg Current Liab	- -	-3.03	-4.17
Common Equity/Total Assets	-1,946.16	-108.73	91.68
Long-Term Debt/Equity (%)	- -	- -	0.55
Long-Term Debt/Capital (%)	- -	- -	0.54
Long-Term Debt/Total Assets (%)	- -	- -	0.5
Total Debt/Equity (%)	- -	- -	0.67
Total Debt/Capital (%)	- -	- -	0.67
Total Debt/Total Assets (%)	- -	- -	0.62
CFO/Total Liabilities	-42.83	-16.05	-305.47
CFO/CapEx	-125.79	-1,123	-187.94
Altman's Z-Score	-73.49	-1.05	14.99

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -
Days Sales Outstanding	- -	- -	- -
Inventory Turnover	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -
Inventory to Cash Days	- -	- -	- -
Inventories	- -	- -	- -
Raw Materials	- -	- -	- -
Work In Process	- -	- -	- -
Finished Goods	- -	- -	- -
Other Inventory	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	832	1,001
- Cash & Cash Equivalents	- -	31	374
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -
+ Total Debt	- -	- -	3
Enterprise Value	- -	676	579
Total Capital	-116	-179	414
Total Debt/Capital (%)	- -	- -	0.67
Total Debt / EV	- -	- -	- -
EV/Sales	- -	- -	- -
EV/EBITDA	- -	- -	- -
EV/EBIT	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -
Diluted Market Cap	- -	832	390
Diluted Enterprise Value	- -	801	19
EV per Share	- -	8.53	7.24
TTM Sales	- -	- -	- -
TTM EBITDA	-65	-81	-145
TTM Operating Income	-65	-81	-146
TTM Cash Flow to Firm	-52	-55	-114
TTM Free Cash Flow to Firm	-52	-55	-113

Multiples (USD)

Valuation Multiples API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-15.13	-3.44
EV/EBIT	- -	- -	- -
Enterprise Value	- -	676	579
Low Price	- -	10.03	8.5
EV/Sales	- -	- -	- -
EV/EBITDA	- -	- -	- -
Price/Earnings	- -	- -	- -
Price/Earnings Average	- -	-11.07	-2.56
Price/Earnings High	- -	-12.36	-3.46
Price/Earnings Low	- -	-10.69	-1.97
Price/Book Value	- -	-4.66	2.44
Price/Book Value Average	- -	-4.6	2.15
Price/Book Value High	- -	-5.14	2.89
Price/Book Value Low	- -	-4.45	1.65
Price/Tangible Book Value	- -	-4.66	2.44
Price/Tangible Book Value Average	- -	-4.6	2.15
Price/Tangible Book Value High	- -	-5.14	2.89
Price/Tangible Book Value Low	- -	-4.45	1.65
Price/Sales	- -	- -	- -
Price/Sales Average	- -	- -	- -
Price/Sales High	- -	- -	- -
Price/Sales Low	- -	- -	- -
Price/Cash Flow	- -	-15.11	-3.42
Price/Cash Flow Average	- -	-14.94	-3.02
Price/Cash Flow High	- -	-16.68	-4.07
Price/Cash Flow Low	- -	-14.44	-2.32
Price/Free Cash Flow Average	- -	-14.95	-3.03
Price/Free Cash Flow High	- -	-16.7	-4.09
Price/Free Cash Flow Low	- -	-14.45	-2.34
EV/Sales Average	- -	- -	- -
EV/Sales High	- -	- -	- -
EV/Sales Low	- -	- -	- -
EV/EBITDA Average	- -	-9.81	-3.52
EV/EBITDA High	- -	-11	-5.64
EV/EBITDA Low	- -	-9.47	-2.13
EV/EBIT Average	- -	-9.78	-3.51
EV/EBIT High	- -	-10.97	-5.61
EV/EBIT Low	- -	-9.44	-2.12
Last Price	- -	10.5	12.52
High Price	- -	11.59	14.87
Enterprise Value Average	- -	791	511
Enterprise Value High	- -	887	819
Enterprise Value Low	- -	763	309

Profitability (USD)

Profitability Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -
Return on Assets (%)	- -	-87.26	-43.76
Return on Capital (%)	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -
Gross Margin (%)	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -
Pretax Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	3
ST Debt	- -	- -	1
LT Debt	- -	- -	2
Total Debt/EBITDA	- -	- -	-0.02
Net Debt/EBITDA	- -	0.38	2.57
Total Debt/EBIT	- -	- -	-0.02
Net Debt/EBIT	- -	0.38	2.56
EBITDA to Interest Expense	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -
Interest Expense	- -	- -	- -
Common Equity/Total Assets	-1,946.16	-108.73	91.68
Long-Term Debt/Equity (%)	- -	- -	0.55
Long-Term Debt/Capital (%)	- -	- -	0.54
Long-Term Debt/Total Assets (%)	- -	- -	0.5
Total Debt/Equity (%)	- -	- -	0.67
Total Debt/Capital (%)	- -	- -	0.67
Total Debt/Total Assets (%)	- -	- -	0.62
Net Debt to Equity	0.22	17.27	-90.9
Net Debt/Capital (%)	0.22	14.73	-930.15
EBITDA	-65	-81	-145
EBITDA-CapEx	-65	-81	-146
Operating Income (Loss)	-65	-81	-146

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.01	7.95	12.14
Current Ratio	0.23	8.1	12.34
Quick Ratio	0.12	7.95	12.15
CFO/Avg Current Liab	- -	-3.03	-4.17
Common Equity/Total Assets	-1,946.16	-108.73	91.68
Long-Term Debt/Equity (%)	- -	- -	0.55
Long-Term Debt/Capital (%)	- -	- -	0.54
Long-Term Debt/Total Assets (%)	- -	- -	0.5
Total Debt/Equity (%)	- -	- -	0.67
Total Debt/Capital (%)	- -	- -	0.67
Total Debt/Total Assets (%)	- -	- -	0.62
CFO/Total Liabilities	-42.83	-16.05	-305.47
CFO/CapEx	-125.79	-1,123	-187.94
Altman's Z-Score	-73.49	-1.05	14.99

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -
Days Sales Outstanding	- -	- -	- -
Inventory Turnover	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -
Inventory to Cash Days	- -	- -	- -
Inventories	- -	- -	- -
Raw Materials	- -	- -	- -
Work In Process	- -	- -	- -
Finished Goods	- -	- -	- -
Other Inventory	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	832	1,001
- Cash & Cash Equivalents	- -	31	374
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -
+ Total Debt	- -	- -	3
Enterprise Value	- -	676	579
Total Capital	-116	-179	414
Total Debt/Capital (%)	- -	- -	0.67
Total Debt / EV	- -	- -	- -
EV/Sales	- -	- -	- -
EV/EBITDA	- -	- -	- -
EV/EBIT	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -
Diluted Market Cap	- -	832	390
Diluted Enterprise Value	- -	801	19
EV per Share	- -	8.53	7.24
TTM Sales	- -	- -	- -
TTM EBITDA	-65	-81	-145
TTM Operating Income	-65	-81	-146
TTM Cash Flow to Firm	-52	-55	-114
TTM Free Cash Flow to Firm	-52	-55	-113

Multiples (USD)

Valuation Multiples API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-15.13	-3.44
EV/EBIT	- -	- -	- -
Enterprise Value	- -	676	579
Low Price	- -	10.03	8.5
EV/Sales	- -	- -	- -
EV/EBITDA	- -	- -	- -
Price/Earnings	- -	- -	- -
Price/Earnings Average	- -	-11.07	-2.56
Price/Earnings High	- -	-12.36	-3.46
Price/Earnings Low	- -	-10.69	-1.97
Price/Book Value	- -	-4.66	2.44
Price/Book Value Average	- -	-4.6	2.15
Price/Book Value High	- -	-5.14	2.89
Price/Book Value Low	- -	-4.45	1.65
Price/Tangible Book Value	- -	-4.66	2.44
Price/Tangible Book Value Average	- -	-4.6	2.15
Price/Tangible Book Value High	- -	-5.14	2.89
Price/Tangible Book Value Low	- -	-4.45	1.65
Price/Sales	- -	- -	- -
Price/Sales Average	- -	- -	- -
Price/Sales High	- -	- -	- -
Price/Sales Low	- -	- -	- -
Price/Cash Flow	- -	-15.11	-3.42
Price/Cash Flow Average	- -	-14.94	-3.02
Price/Cash Flow High	- -	-16.68	-4.07
Price/Cash Flow Low	- -	-14.44	-2.32
Price/Free Cash Flow Average	- -	-14.95	-3.03
Price/Free Cash Flow High	- -	-16.7	-4.09
Price/Free Cash Flow Low	- -	-14.45	-2.34
EV/Sales Average	- -	- -	- -
EV/Sales High	- -	- -	- -
EV/Sales Low	- -	- -	- -
EV/EBITDA Average	- -	-9.81	-3.52
EV/EBITDA High	- -	-11	-5.64
EV/EBITDA Low	- -	-9.47	-2.13
EV/EBIT Average	- -	-9.78	-3.51
EV/EBIT High	- -	-10.97	-5.61
EV/EBIT Low	- -	-9.44	-2.12
Last Price	- -	10.5	12.52
High Price	- -	11.59	14.87
Enterprise Value Average	- -	791	511
Enterprise Value High	- -	887	819
Enterprise Value Low	- -	763	309

Shares Outstanding	79	79	80
Diluted Weighted Avg Shares	79	79	31
Basic Weighted Avg Shares	79	79	31
Revenue per Share	- -	- -	- -
EBITDA per Share	-0.82	-1.02	-4.66
Operating Income per Share	-0.82	-1.02	-4.68
Basic EPS, GAAP	-0.82	-0.94	-4.3
Basic EPS from Cont Ops	-0.82	-0.94	-4.3
Diluted EPS, GAAP	-0.82	-0.94	-4.3
Diluted EPS from Cont Ops	-0.82	-0.94	-4.3
Dividend per Share	- -	- -	- -
Cash Flow per Share	-0.66	-0.69	-3.66
Free Cash Flow per Basic Share	-0.66	-0.7	-3.68
Cash & Equivalents per Share	- -	1.97	5.32
Book Value per Share	-1.46	-2.26	5.14
Tangible Book Value per Share	-1.46	-2.26	5.14

BridgeBio Oncology Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)